PROKIDNEY CORP. - Class A Common Stock (PROK)

CUSIP: 74291D104

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Class A Common Stock
Shares outstanding
141,999,700
Total 13F shares
41,944,849
Share change
+8,493,675
Total reported value
$93,956,490
Put/Call ratio
190%
Price per share
$2.24
Number of holders
61
Value change
+$18,974,610
Number of buys
39
Number of sells
23

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 74291D104?
CUSIP 74291D104 identifies PROK - PROKIDNEY CORP. - Class A Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROKIDNEY CORP. - Class A Common Stock (PROK) as of Q4 2025

As of 31 Dec 2025, PROKIDNEY CORP. - Class A Common Stock (PROK) was held by 61 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,944,849 shares. The largest 10 holders included SUVRETTA CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Bleichroeder LP, Artia Global Partners LP, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, Hennion & Walsh Asset Management, Inc., BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 61 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
55
Q4 2025 holders
61
Holder diff
6
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.